Payment overview · 2025
General Payments
$17.81
1 reported records · 1 companies
Healthcare provider profile · identity verified
Rajendra R Shroff, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · CENTRALIA, IL · NPI 1245259274
Verified facts
What the public records show
CMS Open Payments records show Rajendra R Shroff, M.D. received $17.81 in general payments during 2025 across 1 reported records.
Sumitomo Pharma America, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Gemtesa.
Sumitomo Pharma America, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported GEMTESA as an associated drug or biological on 61692 records involving 22152 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Gemtesa by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Sumitomo Pharma America, Inc. | Unresolved — no canonical attribution shown | $17.81 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.81 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| GEMTESA Normalized: gemtesa |
Drug | Sumitomo Pharma America, Inc. | $17.81 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| GEMTESA gemtesa |
2025 | Gemtesa | 2024 | 13 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Sumitomo Pharma America, Inc. Exact reporting entity; no affiliate inference |
2025 | GEMTESA open payments reported associated product |
CMS Open Payments — General Payments 61692 supporting records · 22152 recipient NPIs · example record 1176593503 |
Gemtesa · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 690 | 135 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 603 | 75 |
| Levothyroxine Sodium | Levothyroxine Sodium | 580 | 113 |
| Potassium Chloride | Potassium Chloride | 568 | 108 |
| Metoprolol Succinate | Metoprolol Succinate | 511 | 104 |
| Amlodipine Besylate | Amlodipine Besylate | 501 | 120 |
| Furosemide | Furosemide | 494 | 98 |
| Eliquis | Apixaban | 407 | 52 |
| Gabapentin | Gabapentin | 379 | 77 |
| Omeprazole | Omeprazole | 374 | 83 |
| Losartan Potassium | Losartan Potassium | 354 | 82 |
| Lorazepam | Lorazepam | 349 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 345 | 74 |
| Lisinopril | Lisinopril | 292 | 64 |
| Citalopram Hbr | Citalopram Hydrobromide | 274 | 48 |
| Metoprolol Tartrate | Metoprolol Tartrate | 236 | 57 |
| Tramadol Hcl | Tramadol Hcl | 236 | 62 |
| Buspirone Hcl | Buspirone Hcl | 211 | 26 |
| Azithromycin | Azithromycin | 206 | 124 |
| Sertraline Hcl | Sertraline Hcl | 206 | 37 |
| Alprazolam | Alprazolam | 200 | 39 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 179 | 39 |
| Metformin Hcl | Metformin Hcl | 178 | 47 |
| Tamsulosin Hcl | Tamsulosin Hcl | 178 | 38 |
| Simvastatin | Simvastatin | 175 | 36 |
| Levetiracetam | Levetiracetam | 170 | 22 |
| Carvedilol | Carvedilol | 167 | 35 |
| Famotidine | Famotidine | 161 | 28 |
| Zolpidem Tartrate | Zolpidem Tartrate | 157 | 31 |
| Allopurinol | Allopurinol | 154 | 35 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 152 | 35 |
| Trazodone Hcl | Trazodone Hcl | 149 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 148 | 31 |
| Risperidone | Risperidone | 146 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 140 | 36 |
| Meloxicam | Meloxicam | 138 | 38 |
| Midodrine Hcl | Midodrine Hcl | 136 | 29 |
| Amoxicillin | Amoxicillin | 130 | 94 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 127 | 50 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 124 | 54 |
| Escitalopram Oxalate | Escitalopram Oxalate | 123 | 17 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 122 | 26 |
| Clonidine Hcl | Clonidine Hcl | 120 | 51 |
| Glimepiride | Glimepiride | 118 | 30 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 116 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 114 | 25 |
| Atenolol | Atenolol | 112 | 26 |
| Montelukast Sodium | Montelukast Sodium | 103 | 22 |
| Linzess | Linaclotide | 100 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 96 | 11 |
| Divalproex Sodium | Divalproex Sodium | 94 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 93 | 17 |
| Warfarin Sodium | Warfarin Sodium | 92 | 16 |
| Donepezil Hcl | Donepezil Hcl | 90 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 88 | suppressed |
| Spironolactone | Spironolactone | 87 | 18 |
| Xarelto | Rivaroxaban | 79 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 76 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 75 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 71 | suppressed |
| Fenofibrate | Fenofibrate | 70 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 70 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 67 | 27 |
| Doxycycline Hyclate | Doxycycline Hyclate | 64 | 48 |
| Ondansetron Hcl | Ondansetron Hcl | 63 | 32 |
| Zonisamide | Zonisamide | 62 | suppressed |
| Memantine Hcl | Memantine Hcl | 60 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 60 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 55 | 15 |
| Lovastatin | Lovastatin | 55 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 55 | 26 |
| Nateglinide | Nateglinide | 54 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 53 | 36 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 52 | 17 |
| Prednisone | Prednisone | 52 | 23 |
| Pregabalin | Pregabalin | 52 | suppressed |
| Finasteride | Finasteride | 51 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 50 | suppressed |
| Baclofen | Baclofen | 49 | suppressed |
| Mirtazapine | Mirtazapine | 49 | 14 |
| Bupropion Xl | Bupropion Hcl | 48 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 48 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 48 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 48 | suppressed |
| Bumetanide | Bumetanide | 47 | suppressed |
| Cephalexin | Cephalexin | 47 | 28 |
| Ezetimibe | Ezetimibe | 47 | 17 |
| Lamotrigine | Lamotrigine | 47 | suppressed |
| Latanoprost | Latanoprost | 47 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 46 | 14 |
| Ondansetron Odt | Ondansetron | 46 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 45 | 11 |
| Memantine Hcl Er | Memantine Hcl | 45 | suppressed |
| Myrbetriq | Mirabegron | 45 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 43 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 43 | suppressed |
| Clonazepam | Clonazepam | 42 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 42 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 41 | 31 |
| Fenofibrate | Fenofibrate Nanocrystallized | 41 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 41 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 41 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 41 | 21 |
| Zaleplon | Zaleplon | 39 | suppressed |
| Lactulose | Lactulose | 38 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 38 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 37 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 36 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 36 | suppressed |
| Januvia | Sitagliptin Phosphate | 36 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 36 | suppressed |
| Topiramate | Topiramate | 36 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 35 | 15 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 35 | 30 |
| Benazepril Hcl | Benazepril Hcl | 34 | suppressed |
| Klor-Con 8 | Potassium Chloride | 34 | suppressed |
| Colchicine | Colchicine | 33 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 33 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 33 | 12 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 31 | suppressed |
| Jardiance | Empagliflozin | 31 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | suppressed |
| Mupirocin | Mupirocin | 30 | 12 |
| Acyclovir | Acyclovir | 29 | suppressed |
| Methylprednisolone | Methylprednisolone | 29 | 22 |
| Aripiprazole | Aripiprazole | 28 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 28 | suppressed |
| Phenobarbital | Phenobarbital | 28 | suppressed |
| Levofloxacin | Levofloxacin | 27 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 26 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 26 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 26 | suppressed |
| Glipizide | Glipizide | 26 | suppressed |
| Olanzapine | Olanzapine | 26 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Nystatin | Nystatin | 25 | 13 |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 24 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 24 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Budesonide | Budesonide | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Folic Acid | Folic Acid | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 17 |
| Sucralfate | Sucralfate | 20 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 19 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Nabumetone | Nabumetone | 18 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 18 |
| Roflumilast | Roflumilast | 18 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 18 | suppressed |
| Repaglinide | Repaglinide | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Tradjenta | Linagliptin | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Haloperidol | Haloperidol | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Novolin R | Insulin Regular, Human | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Celecoxib | Celecoxib | 14 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Ozempic | Semaglutide | 14 | suppressed |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 13 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Gemtesa | Vibegron | 13 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Tresiba | Insulin Degludec | 13 | suppressed |
| Xtampza Er | Oxycodone Myristate | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 12 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 12 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 12 | suppressed |
| Pentoxifylline | Pentoxifylline | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Pulmicort Flexhaler | Budesonide | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.81 · 1 records | Sumitomo Pharma America, Inc. | GEMTESA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Gemtesa play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Sumitomo Pharma America, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error